Funded Tech Companies
Aktis Oncology
Researching who provided funding to Aktis Oncology? Bristol-Myers Squibb, Mirae Asset Venture Investment and Octagon Investments Fund put venture money into this biopharmaceutical company.
Company Overview
Company Name
Aktis Oncology
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Undisclosed
Princeton, NJ 08540
USA
Princeton, NJ 08540
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers. Founded and incubated by MPM Capital, the company has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy.
Last Transaction
8/26/2022
Financing History
Management Team
Company Investors
- Bristol-Myers Squibb
- Mirae Asset Venture Investment
- Octagon Investments Fund
- Cowen Capital Partners
- TCG Crossover
- EcoR1 Capital Management
- MRL Ventures
- Pappas Ventures
- MPM Capital (Todd Foley)
- Vida Ventures
- Novartis
- Timefolio Asset Management
- ArrowMark Partners
- Novartis Venture Fund
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs